These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 18164542

  • 21. [Immunomodulatory treatments for multiple sclerosis: lessons from direct comparative studies].
    Ouallet JC.
    Rev Neurol (Paris); 2010 Jan; 166(1):21-31. PubMed ID: 19596382
    [Abstract] [Full Text] [Related]

  • 22. [Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis].
    Correale J, Cristiano E.
    Medicina (B Aires); 2001 Jan; 61(4):470-80. PubMed ID: 11563177
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Immunomodulating drugs in multiple sclerosis: compliance, satisfaction and adverse effects evaluation in a German multiple sclerosis population.
    Twork S, Nippert I, Scherer P, Haas J, Pöhlau D, Kugler J.
    Curr Med Res Opin; 2007 Jun; 23(6):1209-15. PubMed ID: 17559722
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Combination therapy with interferon-beta and glatiramer acetate in multiple sclerosis.
    Ytterberg C, Johansson S, Andersson M, Olsson D, Link H, Holmqvist LW, von Koch L.
    Acta Neurol Scand; 2007 Aug; 116(2):96-9. PubMed ID: 17661794
    [Abstract] [Full Text] [Related]

  • 29. Modern multiple sclerosis treatment - what is approved, what is on the horizon.
    Pilz G, Wipfler P, Ladurner G, Kraus J.
    Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508
    [Abstract] [Full Text] [Related]

  • 30. Clinical follow-up of 304 patients with multiple sclerosis three years after mitoxantrone treatment.
    Debouverie M, Taillandier L, Pittion-Vouyovitch S, Louis S, Vespignani H.
    Mult Scler; 2007 Jun; 13(5):626-31. PubMed ID: 17548442
    [Abstract] [Full Text] [Related]

  • 31. Therapy of MS.
    Vosoughi R, Freedman MS.
    Clin Neurol Neurosurg; 2010 Jun; 112(5):365-85. PubMed ID: 20362388
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Drug therapy in multiple sclerosis].
    Le Page E, Edan G.
    Rev Prat; 2006 Jun 30; 56(12):1336-46. PubMed ID: 16948222
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The gap between effect of drugs and effectiveness of treatments.
    Sorensen PS.
    J Neurol Sci; 2007 Aug 15; 259(1-2):128-32. PubMed ID: 17362994
    [Abstract] [Full Text] [Related]

  • 36. [Diagnosis and treatment of multiple sclerosis. Update, 2003].
    Jarius S, Hohlfeld R, Voltz R.
    MMW Fortschr Med; 2003 May 26; 145 Suppl 2():88-91, 93, 95. PubMed ID: 14579493
    [Abstract] [Full Text] [Related]

  • 37. Drug insight: using monoclonal antibodies to treat multiple sclerosis.
    Hohlfeld R, Wekerle H.
    Nat Clin Pract Neurol; 2005 Nov 26; 1(1):34-44. PubMed ID: 16932490
    [Abstract] [Full Text] [Related]

  • 38. Update on MS treatment.
    Ryan M.
    J Am Pharm Assoc (Wash); 1996 Jul 26; NS36(7):419-20. PubMed ID: 8840740
    [No Abstract] [Full Text] [Related]

  • 39. The use of interferon Beta and glatiramer acetate in multiple sclerosis.
    Goodin DS.
    Semin Neurol; 2013 Feb 26; 33(1):13-25. PubMed ID: 23709209
    [Abstract] [Full Text] [Related]

  • 40. Therapy of multiple sclerosis in children and adolescents.
    Tenembaum SN.
    Clin Neurol Neurosurg; 2010 Sep 26; 112(7):633-40. PubMed ID: 20471159
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.